Why is lacosamide so expensive?

Lacosamide is often expensive for a few overlapping reasons—some about the drug itself, and some about how the market and pricing work.

1) It’s a newer brand-era specialty anti-seizure drug

• Lacosamide (Vimpat) became widely used after older antiseizure medications. Newer medicines often have higher prices because they were launched under patent protection and were marketed as specialty therapies.

2) Pricing and market structure (brand + limited competition)

• Even if lacosamide is available as a generic in many places, availability and the number of competing manufacturers can still be limited depending on your country/pharmacy system. Less competition usually means higher prices or more frequent “price spikes.”

3) Patent/license history and “exclusive” periods

• In many markets, patents or exclusivity periods can keep generic prices from dropping until those rights expire and multiple generics fully launch at scale.

4) Formulation and dosing complexity

• Lacosamide comes in multiple strengths and forms (tablets, oral solution, IV). Certain formulations (especially oral solution or IV) can stay more expensive due to manufacturing costs, supply logistics, and distribution.

5) Health system incentives and pharmacy pricing

• Insurance formularies, negotiated pharmacy pricing, reimbursement rules, and whether your plan covers it at preferred tiers can greatly affect what you personally pay. Even with generics, copays/coverage tiers can make it feel “expensive.”

If you tell me your country (and whether you mean tablets, oral solution, or IV), I can give more specific reasons and typical cost drivers there.

Also, are you paying out of pocket or through insurance?